Valneva News and Activities

Valneva is owned by Groupe Grimaud. Groupe Grimaud has a direct presence in 3 countries.

Groupe Grimaud has 3 subsidiaries including Valneva, Valneva Austria and Valneva Canada.

They are in:

• Biotechnology50%
• Healthcare50%

View the org chart displaying its 26 main executives

Most searched biographies at Valneva

• Thomas Lingelbach, President and Chief Executive Officer
• James Connolly, Director
• James Sulat, Director

Create your alert
to follow the executive moves at Valneva.

Groupe Grimaud has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).
• NewLimit has just announced a $435 Million fundraising (posted on June 3 2026).
• Rallybio and Avenzo Therapeutics have announced they will merge  (posted on June 1 2026)..

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Valerie Hanote - Non-Executive Director at Eurofins

Learn more about the Biotechnology industry

Press releases by Valneva

• In The News – Valneva

Social media about Valneva

• Valneva on Wikipedia, Google News & Yahoo Finance
• Valneva on LinkedIn, X (Twitter) & YouTube